SARS-CoV-2 spike T cell responses induced upon vaccination or infection remain robust against Omicron
Roanne Keeton(University of Cape Town), Catherine Riou(Université de Limoges), Amy Strydom(University of Pretoria), Alessandro Sette(La Jolla Institute for Immunology), Sango Skelem(University of Cape Town), Glenda Gray(South African Medical Research Council), Mieke A. van der Mescht(University of Pretoria), Annie Bodenstein(Tshwane University of Technology), Ntombi Benede(University of Cape Town), Olukayode O. Aremu(University of Cape Town), Elsa Du Bruyn(Wellcome Centre for Infectious Diseases Research in Africa), Akiko Suzuki(University of Cape Town), Robert J. Wilkinson(The Francis Crick Institute), Sandile Cele(Africa Health Research Institute), Cari Stek(University of Cape Town), Linda‐Gail Bekker(Desmond Tutu HIV Foundation), Daniel Mutithu(University of Cape Town), Ntobeko Ntusi(John Radcliffe Hospital), Marius B. Tincho(University of Cape Town), Sharon Madzorera(National Health Laboratory Service), Thandeka Moyo-Gwete(National Health Laboratory Service), Richard Baguma(University of Cape Town), Gretha van den Berg(Tshwane University of Technology), Farina Karim(Africa Health Research Institute), Talita Roma de Villiers(Tshwane University of Technology), Amkele Ngomti(University of Cape Town), Michael T. Boswell(Steve Biko Hospital), Khadija Khan(Africa Health Research Institute), Marguerite Adriaanse(University of Cape Town), Daniela Weiskopf(Federal Office for Radiation Protection), Alex Sigal(Hebrew University of Jerusalem), Veronica Ueckermann(Steve Biko Hospital), Zelda de Beer(Tshwane University of Technology), Alba Grifoni(La Jolla Institute for Immunology), Marietjie Venter(University of the Witwatersrand), Theresa M. Rossouw(University of Pretoria), Adriano Mendes(University of Pretoria), Mathilda Mennen(University of Cape Town), Penny L. Moore(National Health Laboratory Service), Wendy A. Burgers(University of Cape Town), Jinal Bihman(National Health Laboratory Service), Mallory Bernstein(Africa Health Research Institute)
Cited by 72
Related Papers
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
|Cell|2020|4k
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
|New England Journal of Medicine|2021|2.6k